---
figid: PMC5889282__koni-07-04-1373233-g007
figtitle: BGN- and DCN-mediated inhibition of the TGFB pathway and restriction of
  HER-2/neu signaling
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC5889282
filename: koni-07-04-1373233-g007.jpg
figlink: /pmc/articles/PMC5889282/figure/f0007/
number: F7
caption: Schematic representation of BGN- and DCN-mediated inhibition of the TGF-β
  pathway and restriction of HER-2/neu signaling. TGF-β1 binds to its receptors (TGF-βRI
  and TGF-βR2) and induces phosphorylation of TACE, resulting in its translocation
  to the cell surface, where TACE induces integrins and cleaves EGFR pro-ligands.
  EGFR ligands will initiate autocrine and paracrine EGFR signaling, which is amplified
  in HER2-overexpressing cells (BGNlow/neg HER-2/neu+ cells). In BGNhigh HER-2/neu+
  cells, BGN and DCN bind to TGF-β1 and restricts HER-2/neu signaling, thus allowing
  tumor suppression to occur.
papertitle: Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed
  cells.
reftext: Karthikeyan Subbarayan, et al. Oncoimmunology. 2018;7(4):e1373233.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9365126
figid_alias: PMC5889282__F7
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC5889282__F7
ndex: f8e67aaf-de9c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5889282__koni-07-04-1373233-g007.html
  '@type': Dataset
  description: Schematic representation of BGN- and DCN-mediated inhibition of the
    TGF-β pathway and restriction of HER-2/neu signaling. TGF-β1 binds to its receptors
    (TGF-βRI and TGF-βR2) and induces phosphorylation of TACE, resulting in its translocation
    to the cell surface, where TACE induces integrins and cleaves EGFR pro-ligands.
    EGFR ligands will initiate autocrine and paracrine EGFR signaling, which is amplified
    in HER2-overexpressing cells (BGNlow/neg HER-2/neu+ cells). In BGNhigh HER-2/neu+
    cells, BGN and DCN bind to TGF-β1 and restricts HER-2/neu signaling, thus allowing
    tumor suppression to occur.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DCN
  - ADAM17
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - TGFBR2
  - TGFB1
  - TGFB2
  - TGFB3
  - ERBB2
  - BGN
  - EGFR
  - TGFBR1
  - Dcn
  - Adam17
  - Tgfbr2
  - Tgfb1
  - Ltbp1
  - Erbb2
  - Bgn
  - Egfr
  - Tgfbr1
---
